Monoubiquitination empowers ubiquitin chain elongation
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.105753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Kenneth Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: beta Catenin, Ubiquitin, Ubiquitination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH.
Abstract (Originalsprache)
Ubiquitination often generates lysine 48-linked polyubiquitin chains that signal proteolytic destruction of the protein target. A significant subset of ubiquitination proceeds by a priming/extending mechanism, in which a substrate is first monoubiquitinated with a priming E2-conjugating enzyme or a set of E3 ARIH/E2 enzymes specific for priming. This is then followed by ubiquitin (Ub) chain extension catalyzed by an E2 enzyme capable of elongation. This report provides further insights into the priming/extending mechanism. We employed reconstituted ubiquitination systems of substrates CK1α (casein kinase 1α) and β-catenin by Cullin-RING E3 Ub ligases (CRLs) CRL4CRBN and CRL1βTrCP, respectively, in the presence of priming E2 UbcH5c and elongating E2 Cdc34b (cell division cycle 34b). We have established a new "apyrase chase" strategy that uncouples priming from chain elongation, which allows accurate measurement of the decay rates of the ubiquitinated substrate with a defined chain length. Our work has revealed highly robust turnover of monoubiquitinated β-catenin that empowers efficient polyubiquitination. The results of competition experiments suggest that the interactions between the ubiquitinated β-catenin and CRL1βTrCP are highly dynamic. Moreover, ubiquitination of the Ub-modified β-catenin appeared more resistant to inhibition by competitors than the unmodified substrate, suggesting tighter binding with CRL1βTrCP. These findings support a role for conjugated Ub in enhancing interactions with E3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Pharmacological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA; Drug Discovery Institute, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Oncological Sciences, The Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: zhen-qiang.pan@mssm.edu.
Förderung
- NCI NIH HHS
- NIH
Zitieren
APA
Wu, K., DeVita, R. J., & Pan, Z. Q. (2024). Monoubiquitination empowers ubiquitin chain elongation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.105753
Vancouver
Wu K, DeVita RJ, Pan ZQ. Monoubiquitination empowers ubiquitin chain elongation. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.105753
BibTeX
@article{Wu2024,
author = {Wu, Kenneth and DeVita, Robert J and Pan, Zhen-Qiang},
title = {Monoubiquitination empowers ubiquitin chain elongation},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.105753}
}
EUVIMED